How Nitrosamine Impurities Affect Your Blood Pressure Medicine

How nitrosamine affects blood pressure medicine

Guest Author: Phil Koerner, PhD. The U.S. Food and Drug Administration (USFDA) and The European Medicines Agency (EMA) have set legally-binding limits for nitrosamine impurities in sartan blood pressure medicines. Continue Reading

Sartan Drugs Have Been Deemed in Shortage by the FDA

sartan drugs

The US Food and Drug Administration (FDA) is warning that there is a shortage of drugs that is used by millions to treat high blood pressure. The drugs known as Continue Reading